Today in News History
On July 12, several notable moments in the history of News stand out. In 965, Meng Chang, emperor of Later Shu (born 919) passed away. In 981, Xue Juzheng, Chinese scholar-official and historian passed away. In 1854, George Eastman, American businessman, founded Eastman Kodak (died 1933) was born. In 1913, The Second Revolution breaks out against the Beiyang government, as Li Liejun proclaims Jiangxi independent from the Republic of China. In 1933, Victor Poor, American engineer, developed the Datapoint 2200 (died 2012) was born. In 1995, Chinese seismologists successfully predict the 1995 Myanmar-China earthquake, reducing the number of casualties to 11. In 2006, The 2006 Lebanon War begins. In 2013, Amar Bose, American businessman, founded the Bose Corporation (born 1929) passed away. In 2015, Cheng Siwei, Chinese engineer, economist, and politician (born 1935) passed away. In 2015, Tenzin Delek Rinpoche, Tibetan monk and activist (born 1950) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.
China AI drug-design deals swell as US scrutiny mounts
Riding a wave of booming cross-border dealmaking, China’s AI-driven drug-design firms are charging onto the global stage despite Washington’s growing scrutiny of Chinese biotech firms. The value of out-licensing deals struck by Chinese biotech companies with top global multinational pharmaceutical companies climbed to US75 billion in the first five months of 2026, up from zero before 2020, according to Linda Shu, head of China healthcare research at HSBC. In total, over the five months, these...
Narrative Intelligence Brief
This article was published by South China Morning Post, a source frequently categorized with a lean left bias based in Hong Kong. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of South China Morning Post, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.
More from South China Morning Post
July 12, 2026
Japan wants 60 million tourists, but China isn’t sending them
July 12, 2026
EU isn’t just selling aircraft to China. It’s helping strengthen a competitor
July 12, 2026
Chinese court holds 3 liable after man dies following all-night drinking, mahjong session
July 12, 2026
Youth suicides in Hong Kong hit 10-year high: court report
July 12, 2026
Iran declares Strait of Hormuz closed, US launches new strikes
Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.More Coverage
Discussion
"cup semifinals"
Jude Bellingham's star shines as risk-averse England advance to World Cup semifinals over tepid Norway
Bellingham carries England past Norway and into World Cup semifinals
England defeat Norway 2-1 as Jude Bellingham shines in World Cup quarterfinal
How other outlets are covering this story
Compare narratives across 6 related reports from 6 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.
Coverage bias distribution
6 sources
Left 17%
Center 17%
Right 50%
AzerNews
· Jun 29, 2026
Why U.S. pharma giants are betting bigger on China's innovation ecosystem?
From AI-assisted high-complexity cardiovascular interventions—where digital algorithms pre-simulate intricate surgical workflows, accurately predict intraoperative risks, and tailor personalized treatment plans to significantly boost procedural efficiency—to AI-powered FFRangio systems that slash measurement time from 20 minutes to just four... As China, the world's second-largest pharmaceutical market, is rapidly transcending its traditional role from a low-cost manufacturing base to a co-developer of cutting-edge therapies and a vital node in global RD networks, an increasing number of multinational pharmaceutical companies are reshaping their investment and partnership strategies on the ground.
UrduPoint
· Jun 28, 2026
Multinational healthcare companies expand R&D, supply chain links in China
Multinational healthcare companies expand R&D, supply chain links in China
Atlantic Council
· Jun 23, 2026
Balancing openness and control: Cross-border health data and AI governance in China
In China, health data is no longer just a medical resource—it is a strategic asset at the center of AI competition. The post Balancing openness and control: Cross-border health data and AI governance in China appeared first on Atlantic Council.
The Motley Fool
· Jul 10, 2026
Vertex Pharmaceuticals Just Made a $10 Billion Move. Is the Stock a Buy?
Additional blockbuster drugs may be on the horizon.
Drudge Report
· Jul 9, 2026
ChinaRussiaIran Seek to Inflame Debate Over Data Centers...
ChinaRussiaIran Seek to Inflame Debate Over Data Centers... (First column, 2nd story, link) Related stories:Nobel-Winning U.S. Chemist Will Move to China to Lead A.I. Institute...Big Tech Now Targeting Native American Land...The great hub cover-up...Public Offerings Spark FOMO Among San Fran Home Buyers...Doom Loop Replaced by Land Grab...Race to buy private jets...
The Japan Times
· Jul 3, 2026
A new, inexpensive Chinese AI model is catching up with Anthropic, OpenAI on their home turf
Z.ai's GLM-5.2 model has been put at the heart of a growing debate about whether China is finally catching up to the U.S. in the artificial intelligence race.
Topics:
Related coverage for "China AI drug-design deals swell as US scrutiny mounts": AzerNews — Why U.S. pharma giants are betting bigger on China's innovation ecosystem?. UrduPoint — Multinational healthcare companies expand R&D, supply chain links in China. Atlantic Council — Balancing openness and control: Cross-border health data and AI governance in China. The Motley Fool — Vertex Pharmaceuticals Just Made a $10 Billion Move. Is the Stock a Buy?. Drudge Report — ChinaRussiaIran Seek to Inflame Debate Over Data Centers.... The Japan Times — A new, inexpensive Chinese AI model is catching up with Anthropic, OpenAI on their home turf